Form 4 for BBNX Beta Bionics, Inc.
Accepted 2026-09-04 17:19:25 ET · period of report 2026-09-03 · accession 0002048593-26-000010 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-09-04 17:19 | 2026-09-03 | BBNX | Saint Sean | Pres, CEO, Dir | S - Sale | $20.08 | -5,641 | 398.4K | -1% | -$113.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-09-03 | S | D | 5,641 | $20.08 | 398,429 | D | — | — | (F1) Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on September 5, 2025. (F2) The weighted average sale price for the transaction reported was $20.0778 and the range of prices were between $20.00 and $20.1696. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. |